Wednesday, February 10, 2010, 6:17pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Albany Molecular Research Inc. (AMRI)

At 5:00AM SGT: 8.46 USD   0.00 (0.00%)  
 MORE ON AMRI 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Albany Molecular Research, Inc. (NasdaqNM:AMRI) Delayed quote dataEdit
Last Trade:8.46 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:8.46
Open:N/A
Bid:N/A
Ask:9.40 x 100
1y Target Est:8.00
Day's Range:N/A - N/A
52wk Range:7.31 - 11.31
Volume:0
Avg Vol (3m):79,355.6
Market Cap:267.70M
P/E (ttm):46.74
EPS (ttm):0.18
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add AMRI to Portfolio   Download Data

 HEADLINES 
•AMRI reports $19M net loss in 4Q
at bizjournals.com (Mon, Feb 8)
•ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online (Mon, Feb 8)
•AMRI Announces Fourth Quarter 2009 Results
Business Wire (Mon, Feb 8)
•AMRI CFO to Present at UBS 20th Annual Global Healthcare Services Conference
Business Wire (Tue, Feb 2)
•AMRI to Announce Fourth Quarter Results
Business Wire (Mon, Feb 1)
•Research And Development Expenditures In Diagnostic And Lab Equipment Sector Raises Capital Requirements: Will Acquisitions By Larger Health Care Companies Be The Result?
Wall Street Transcript (Thu, Jan 28)
•AMRI CFO to Present at Jefferies 2010 Global Healthcare Services Conference
Business Wire (Wed, Jan 20)
•AMRI Receives SafeBridge® Potent Compound Safety Certification
Business Wire (Tue, Jan 19)
•AMRI CEO to Present at 28th Annual J.P. Morgan Healthcare Conference
Business Wire (Thu, Jan 7)
•Bruno name stays put in Capital Region
at bizjournals.com (Thu, Dec 10)
More Headlines for AMRI...
 ANALYST 
EPS Est (next year) (Dec-09) :0.03
EPS Est (in 2 years) (Dec-10) :0.17
Avg Rec (current)*:3.0
PEG Ratio:31.27
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States and Europe.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices